EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Response to Proton‐Pump Inhibitors Therapy in Pediatric Patients With Eosinophilic Esophagitis in Bogotá, Colombia

Andrea Estefanía Rodríguez López iD, José Fernando Vera Chamorro iD, Ailim Margarita Carias Domínguez iD, Mónica Viviana Pinilla Roncancio iD, Rocío Del Pilar López Panqueva iD, Gonzalo Andrés Montaño Rozo iD

Canadian Journal of Gastroenterology and Hepatology · 2025

DOI: 10.1155/cjgh/4633813 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, 2025. Verfasst von Andrea Estefanía Rodríguez López und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Universidad de Los Andes, Bogotá, Colombia, uandes.cl. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Eosinophilic Esophagitis. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Eosinophilic esophagitis (EoE) is a chronic immune‐mediated disease and a leading cause of food impaction in pediatric populations, with potential functional and structural complications. Proton‐pump inhibitors (PPIs) are widely used as first‐line therapy, but the response rate in Colombian children remains unknown. This study aimed to determine the initial histologic response to PPI therapy and describe clinical, endoscopic, and histological characteristics in a sample of pediatric patients with EoE from Bogotá, Colombia. Methodology A retrospective observational longitudinal study of patients aged 2–18 years diagnosed with EoE at a tertiary care center between 2015 and 2022 was conducted. Patients underwent initial clinical and endoscopic assessment confirming esophageal eosinophilia (≥ 15 eosinophils per high‐power field [eos/hpf]), followed by at least 8‐week course of PPI therapy and a subsequent clinical‐endoscopic re‐evaluation. Treatment response was defined histologically as < 15 eos/hpf in follow‐up esophageal biopsy. Demographic, clinical, endoscopic, and histological data were analyzed using descriptive and bivariate statistics.

Results

We included 34 patients (median age 11 years; 61.8% boys). Sixteen (47%) achieved histological remission with initial PPI therapy. Being esomeprazole preferred in 88%, with median dose 1.37 mg/kg/day. No significant differences were observed between responders and nonresponders in demographic variables, familial and personal atopic history, symptoms, or endoscopic findings. Histologically, responders demonstrated significant reductions in eosinophil counts, as well as improvements in basal zone hyperplasia, eosinophilic abscesses, and eosinophil surface layering (all p < 0.005).

Discussion

This is the first study to assess PPI response in Colombian pediatric EoE patients, demonstrating a response rate consistent with existing literature. Histologic evaluation was identified as the most reliable marker of treatment success, underscoring the critical role of histopathological follow‐up in this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsEosinophilic EsophagitisHumansChildMaleFemaleColombiaAdolescentRetrospective StudiesChild, PreschoolLongitudinal StudiesTreatment OutcomeEsophagoscopyBiopsyEsomeprazoleEsophagus

Substanzen

Proton Pump InhibitorsEsomeprazole

Autor:innen und Institutionen

  • School of Medicine, Universidad de Los Andes, Bogotá, Colombia, uandes.cl.
  • Department of Pediatrics, Fundación Santa Fe de Bogotá, Bogotá, Colombia, fsfb.org.co.
  • Department of Anatomic Pathology and Clinical Laboratory, Fundación Santa Fe de Bogotá, Bogotá, Colombia, fsfb.org.co.

ORCID-Profile: Andrea Estefanía Rodríguez López, José Fernando Vera Chamorro, Ailim Margarita Carias Domínguez, Mónica Viviana Pinilla Roncancio, Rocío Del Pilar López Panqueva, Gonzalo Andrés Montaño Rozo

Zitieren

APA

Rodríguez López, A. E., Vera Chamorro, J. F., Carias Domínguez, A. M., Pinilla Roncancio, M. V., López Panqueva, R. D. P., & Montaño Rozo, G. A. (2025). Response to Proton‐Pump Inhibitors Therapy in Pediatric Patients With Eosinophilic Esophagitis in Bogotá, Colombia. Canadian Journal of Gastroenterology and Hepatology. https://doi.org/10.1155/cjgh/4633813

Vancouver

Rodríguez López AE, Vera Chamorro JF, Carias Domínguez AM, Pinilla Roncancio MV, López Panqueva RDP, Montaño Rozo GA. Response to Proton‐Pump Inhibitors Therapy in Pediatric Patients With Eosinophilic Esophagitis in Bogotá, Colombia. Canadian Journal of Gastroenterology and Hepatology. 2025. doi:10.1155/cjgh/4633813

BibTeX
@article{RodrguezLpez2025,
  author = {Rodríguez López, Andrea Estefanía and Vera Chamorro, José Fernando and Carias Domínguez, Ailim Margarita and Pinilla Roncancio, Mónica Viviana and López Panqueva, Rocío Del Pilar and Montaño Rozo, Gonzalo Andrés},
  title = {Response to Proton‐Pump Inhibitors Therapy in Pediatric Patients With Eosinophilic Esophagitis in Bogotá, Colombia},
  journal = {Canadian Journal of Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1155/cjgh/4633813}
}
Kostenlos starten →